{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:47:17Z","timestamp":1788202037661,"version":"build-2803163510"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:sec id=\"ab-dcs230003-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Although several clinician- and patient-reported outcome measures have been developed for trials in hidradenitis suppurativa (HS), there is currently no consensus on which measures are best suited for use in clinical practice. Identifying validated and feasible measures applicable to the practice setting has the potential to optimize treatment strategies and generate generalizable evidence that may inform treatment guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-dcs230003-2\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To establish consensus on a core set of clinician- and patient-reported outcome measures recommended for use in clinical practice and to establish the appropriate interval within which these measures should be applied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-dcs230003-3\">\n                    <jats:title>Evidence Review<\/jats:title>\n                    <jats:p>Clinician- and patient-reported HS measures and studies describing their psychometric properties were identified through literature reviews. Identified measures comprised an item reduction survey and subsequent electronic Delphi (e-Delphi) consensus rounds. In each consensus round, a summary of outcome measure components and scoring methods was provided to participants. Experts were provided with feasibility characteristics of clinician measures to aid selection. Consensus was achieved if at least 67% of respondents agreed with use of a measure in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-dcs230003-4\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Among HS experts, response rates for item reduction, e-Delphi round 1, and e-Delphi round 2 surveys were 76.4% (42 of 55), 90.5% (38 of 42), and 92.9% (39 of 42), respectively; among patient research partners (PRPs), response rates were 70.8% (17 of 24), 100% (17 of 17), and 82.4% (14 of 17), respectively. The majority of experts across rounds were practicing dermatologists with 18 to 19 years of clinical experience. In the final e-Delphi round, most PRPs were female (12 [85.7%] vs 2 males [11.8%]) and aged 30 to 49 years. In the final e-Delphi round, HS experts and PRPs agreed with the use of the HS Investigator Global Assessment (28 [71.8%]) and HS Quality of Life score (13 [92.9%]), respectively. The most expert-preferred assessment interval in which to apply these measures was 3 months (27 [69.2%]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-dcs230003-5\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>An international group of HS experts and PRPs achieved consensus on a core set of HS measures suitable for use in clinical practice. Consistent use of these measures may lead to more accurate assessments of HS disease activity and life outcomes, facilitating shared treatment decision-making in the practice setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamadermatol.2023.3282","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T11:34:46Z","timestamp":1695814486000},"page":"1258","source":"Crossref","is-referenced-by-count":20,"title":["Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice"],"prefix":"10.1001","volume":"159","author":[{"given":"Nicole","family":"Mastacouris","sequence":"first","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Tannenbaum","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Strunk","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Koptyev","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim","family":"Aarts","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed","family":"Alhusayen","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute, Division of Dermatology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk G.","family":"Bechara","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Ruhr-University, Bochum, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Benhadou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, H\u00f4pital Universitaire de Bruxelles, CUB H\u00f4pital Erasme, Universit\u00e9 libre de Bruxelles, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Bettoli","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, O.U. of Dermatology, Azienda Ospedaliera, University of Ferrara, Ferrara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Brassard","sequence":"additional","affiliation":[{"name":"University of California, Davis, Sacramento, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Brown","sequence":"additional","affiliation":[{"name":"Medical Dermatology, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Eng","family":"Choon","sequence":"additional","affiliation":[{"name":"Hospital Sultanah Aminah and Clinical School Johor Bahru, Monash University Malaysia, Johor Bahru, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Coutts","sequence":"additional","affiliation":[{"name":"Independent Consultant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri Luz Felipe","family":"da Silva","sequence":"additional","affiliation":[{"name":"University Santo Amaro, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Daveluy","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Wayne State University, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Dellavalle","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Colorado Anschutz School of Medicine, Aurora, Colorado"},{"name":"Dermatology Service, Eastern Colorado Health Care System, US Department of Veterans Affairs, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"del Marmol","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Emtestam","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Dermatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Gebauer","sequence":"additional","affiliation":[{"name":"University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"George","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Goldfarb","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Dermatology, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iltefat","family":"Hamzavi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Henry Ford Health System, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Hazen","sequence":"additional","affiliation":[{"name":"Case-Western Reserve University School of Medicine, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Ingram","sequence":"additional","affiliation":[{"name":"Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor B. E.","family":"Jemec","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Zealand University Hospital, Roskilde, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joslyn S.","family":"Kirby","sequence":"additional","affiliation":[{"name":"Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Lowes","sequence":"additional","affiliation":[{"name":"The Rockefeller University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo V.","family":"Marzano","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Matusiak","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley B.","family":"Naik","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin M.","family":"Okun","sequence":"additional","affiliation":[{"name":"Fort HealthCare, Fort Atkinson, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel H.","family":"Oon","sequence":"additional","affiliation":[{"name":"National Skin Centre, Singapore, Singapore City, Singapore"},{"name":"Lee Kong Chian School of Medicine, Singapore City, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A. V.","family":"Orenstein","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Yeon","family":"Paek","sequence":"additional","affiliation":[{"name":"Baylor University Medical Center, Dallas, Texas A&M University School of Medicine, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 C.","family":"Pascual","sequence":"additional","affiliation":[{"name":"Dermatology Department, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research, Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Fernandez-Pe\u00f1as","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Westmead Hospital, The University of Sydney, Westmead, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry I.","family":"Resnik","sequence":"additional","affiliation":[{"name":"Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Sayed","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of North Carolina School of Medicine, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnea","family":"Thorlacius","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Zealand University Hospital, Roskilde, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessel H.","family":"van der Zee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey R.","family":"van Straalen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Garg","sequence":"additional","affiliation":[{"name":"Northwell Health, New Hyde Park, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"dcs230003r1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part II: topical, intralesional, and systemic medical management.","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"dcs230003r2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the Global Survey of Impact and Healthcare Needs (VOICE) Project.","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"dcs230003r3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/bjd.21798","article-title":"Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.","volume":"187","author":"Midgette","year":"2022","journal-title":"Br J Dermatol"},{"issue":"12","key":"dcs230003r4","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1001\/jamadermatol.2022.4211","article-title":"Measuring atopic eczema control and itch intensity in clinical practice: a consensus statement from the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative.","volume":"158","author":"Leshem","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"5","key":"dcs230003r5","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s10067-017-3962-5","article-title":"Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice.","volume":"37","author":"Versteeg","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"4","key":"dcs230003r6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/annrheumdis-2019-216819","article-title":"Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).","volume":"79","author":"Ramiro","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"10012","key":"dcs230003r7","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/S0140-6736(15)00347-5","article-title":"Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial.","volume":"386","author":"Coates","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"dcs230003r8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000526069","article-title":"Demographic gaps and requirements for participation: a systematic review of clinical trial designs in hidradenitis suppurativa.","volume":"239","author":"James","year":"2023","journal-title":"Dermatology"},{"issue":"1","key":"dcs230003r9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/bjd\/ljac018","article-title":"Pain experiences among those living with hidradenitis suppurativa: a qualitative study.","volume":"188","author":"Orenstein","year":"2023","journal-title":"Br J Dermatol"},{"issue":"4","key":"dcs230003r10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jamadermatol.2020.5857","article-title":"Expert knowledge, attitudes, and practices in management of hidradenitis suppurativa pain.","volume":"157","author":"Jedrzejczak","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"2","key":"dcs230003r11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40271-021-00539-7","article-title":"Identifying unmet care needs and important treatment attributes in the management of hidradenitis suppurativa: a qualitative interview study.","volume":"15","author":"Willems","year":"2022","journal-title":"Patient"},{"issue":"2","key":"dcs230003r12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000528253","article-title":"Low rates of psychosocial screening and lifestyle counseling in hidradenitis suppurativa patients in the USA.","volume":"9","author":"Shih","year":"2023","journal-title":"Skin Appendage Disord"},{"issue":"3","key":"dcs230003r15","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/bjd.16672","article-title":"A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process.","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"dcs230003r16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/bjd.v187.2","article-title":"Development and initial validation of the HS-IGA: a novel hidradenitis suppurativa-specific investigator global assessment for use in interventional trials.","volume":"187","author":"Garg","year":"2022","journal-title":"Br J Dermatol"},{"issue":"6","key":"dcs230003r17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jamadermatol.2023.0797","article-title":"Validation of the Hidradenitis Suppurativa Investigator Global Assessment: a novel hidradenitis suppurativa\u2013specific investigator global assessment for use in interventional trials.","volume":"159","author":"Garg","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"5","key":"dcs230003r18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/bjd.v184.5","article-title":"Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment.","volume":"184","author":"Goldfarb","year":"2021","journal-title":"Br J Dermatol"},{"issue":"2","key":"dcs230003r19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/bjd.v183.2","article-title":"The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials.","volume":"183","author":"Kirby","year":"2020","journal-title":"Br J Dermatol"},{"issue":"7","key":"dcs230003r20","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/jdv.v35.7","article-title":"Convergent validity of suffering and quality of life as measured by the hidradenitis suppurativa quality of life.","volume":"35","author":"Kursawe Larsen","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"dcs230003r21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/bjd.v184.4","article-title":"Validation of global item for assessing impact on quality of life of patients with hidradenitis suppurativa.","volume":"184","author":"Kirby","year":"2021","journal-title":"Br J Dermatol"},{"issue":"4","key":"dcs230003r22","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/bjd.v184.4","article-title":"Hidradenitis suppurativa odour and drainage scale: a novel method for evaluating odour and drainage in patients with hidradenitis suppurativa.","volume":"184","author":"Machado","year":"2021","journal-title":"Br J Dermatol"},{"issue":"8","key":"dcs230003r23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/0269216317690685","article-title":"Guidance on Conducting and Reporting Delphi Studies (CREDES) in palliative care: recommendations based on a methodological systematic review.","volume":"31","author":"J\u00fcnger","year":"2017","journal-title":"Palliat Med"},{"issue":"12","key":"dcs230003r24","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process.","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"issue":"1","key":"dcs230003r25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0895-4356(02)00537-1","article-title":"Comparative responsiveness of generic and specific quality-of-life instruments.","volume":"56","author":"Wiebe","year":"2003","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"dcs230003r26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/bjd.2017.177.issue-5","article-title":"Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.","volume":"177","author":"Zouboulis","year":"2017","journal-title":"Br J Dermatol"},{"issue":"12","key":"dcs230003r27","doi-asserted-by":"publisher","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"issue":"6","key":"dcs230003r28","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/bjd.13270","article-title":"Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.","volume":"171","author":"Kimball","year":"2014","journal-title":"Br J Dermatol"},{"issue":"3","key":"dcs230003r29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamadermatol.2017.5890","article-title":"A novel severity assessment scoring system for hidradenitis suppurativa.","volume":"154","author":"Hessam","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"2","key":"dcs230003r30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"dcs230003r31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/09546634.2017.1341614","article-title":"Development and initial psychometric evaluation of patient-reported outcome questionnaires to evaluate the symptoms and impact of hidradenitis suppurativa.","volume":"29","author":"Kimball","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"dcs230003r32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jdin.2022.11.003","article-title":"Evaluating the hidradenitis odor and drainage scale (HODS): a new validated potential instrument to assess odor and drainage in hidradenitis suppurativa-a cross-sectional study.","volume":"10","author":"Alavi","year":"2022","journal-title":"JAAD Int"},{"issue":"5","key":"dcs230003r33","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jaad.2015.07.046","article-title":"Pain management in patients with hidradenitis suppurativa.","volume":"73","author":"Horv\u00e1th","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"dcs230003r34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000501771","article-title":"Could residents adequately assess the severity of hidradenitis suppurativa? interrater and intrarater reliability assessment of major scoring systems.","volume":"236","author":"Wlodarek","year":"2020","journal-title":"Dermatology"},{"issue":"11","key":"dcs230003r35","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1111\/jdv.v34.11","article-title":"Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.","volume":"34","author":"Gergely","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"dcs230003r36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/life11010034","article-title":"Quality-of-life impairment among patients with hidradenitis suppurativa: a cross-sectional study of 1795 patients.","volume":"11","author":"Krajewski","year":"2021","journal-title":"Life (Basel)"},{"issue":"3","key":"dcs230003r37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000520839","article-title":"Patients with hidradenitis suppurativa suffer from low health-related quality of life as measured by the Generic 15D Instrument.","volume":"8","author":"Hirvonen","year":"2022","journal-title":"Skin Appendage Disord"},{"issue":"4","key":"dcs230003r38","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/bjd.v181.4","article-title":"Inter-rater and intrarater agreement and reliability in clinical staging of hidradenitis suppurativa\/acne inversa.","volume":"181","author":"Zouboulis","year":"2019","journal-title":"Br J Dermatol"},{"issue":"2","key":"dcs230003r39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/ced.v47.2","article-title":"Assessment of inter-rater reliability of clinical hidradenitis suppurativa outcome measures using ultrasonography.","volume":"47","author":"Lyons","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"dcs230003r40","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/bjd.v182.2","article-title":"Concordance of severity scores for photographic assessment of hidradenitis suppurativa.","volume":"182","author":"Prouteau","year":"2020","journal-title":"Br J Dermatol"},{"issue":"3","key":"dcs230003r41","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/bjd.v181.3","article-title":"Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa.","volume":"181","author":"Thorlacius","year":"2019","journal-title":"Br J Dermatol"},{"issue":"12","key":"dcs230003r42","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1111\/jdv.2018.32.issue-12","article-title":"Reliability of the hidradenitis suppurativa clinical response in the assessment of patients with hidradenitis suppurativa.","volume":"32","author":"Kimball","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"dcs230003r43","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/j.pain.0000000000001117","article-title":"Core outcome measurement instruments for clinical trials in nonspecific low back pain.","volume":"159","author":"Chiarotto","year":"2018","journal-title":"Pain"},{"issue":"3","key":"dcs230003r44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/der2.v3.3","article-title":"Combining medical and surgical management strategies for hidradenitis suppurativa: need for a treat to target approach.","volume":"3","author":"Lowes","year":"2022","journal-title":"Dermatol Rev"},{"key":"dcs230003r45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/exd.v31.S1","article-title":"New treatments and new assessment instruments for Hidradenitis suppurativa.","volume":"31","author":"van Straalen","year":"2022","journal-title":"Exp Dermatol"},{"issue":"6","key":"dcs230003r46","doi-asserted-by":"publisher","first-page":"967","DOI":"10.5114\/ada.2020.97064","article-title":"Hidradenitis Suppurativa Quality of Life (HiSQOL): creation and validation of the Polish language version.","volume":"38","author":"Krajewski","year":"2021","journal-title":"Postepy Dermatol Alergol"},{"issue":"5","key":"dcs230003r48","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/bjd\/ljac141","article-title":"Initial validation of the Hidradenitis Suppurativa Quality of Life tool in a clinical trial setting.","volume":"188","author":"Santos","year":"2023","journal-title":"Br J Dermatol"},{"issue":"4","key":"dcs230003r49","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/ard.2010.128462","article-title":"\u2018Treat to target\u2019: moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis.","volume":"69","author":"Atar","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"14","key":"dcs230003r50","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"issue":"9118","key":"dcs230003r51","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial.","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"dcs230003r52","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001083","article-title":"Treat-to-target in PsA: methods and necessity.","volume":"6","author":"Dures","year":"2020","journal-title":"RMD Open"},{"issue":"1","key":"dcs230003r53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.","volume":"75","author":"Smolen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"dcs230003r47","author":"Ingram","year":"2022"},{"key":"dcs230003r13","unstructured":"HiSTORIC: Hidradenitis Suppurativa Core Outcomes Set International Collaboration. Disease state: hidradenitis suppurativa. CHORD Foundation. Updated April 27, 2023. Accessed July 7, 2023. https:\/\/www.c3outcomes.org\/historic"},{"key":"dcs230003r14","unstructured":"The CHORD COUSIN Collaboration. CHORD Foundation. Accessed July 7, 2023. https:\/\/www.c3outcomes.org\/"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2809656\/jamadermatology_mastacouris_2023_cs_230003_1699989227.3196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T11:02:45Z","timestamp":1700046165000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2809656"}},"subtitle":["A HiSTORIC Consensus Statement"],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2023.3282","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}